Preferred Label : Darolutamide/Docetaxel Regimen;
NCIt synonyms : Nubeqa/Docetaxel; Docetaxel-Nubeqa; Docetaxel-Darolutamide; Darolutamide-Docetaxel; Docetaxel/Darolutamide Regimen;
NCIt definition : A regimen consisting of darolutamide and docetaxel that can be used for the treatment
of metastatic hormone-sensitive prostate cancer.;
NCI Metathesaurus CUI : CL1794017;
Origin ID : C188870;
UMLS CUI : C5708098;
Semantic type(s)
chemotherapy_regimen_has_component
concept_is_in_subset
https://www.has-sante.fr/jcms/p_3477070/fr/nubeqa-darolutamide-cancer-de-la-prostate-hormonosensible-metastatique-cphsm
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, oral
antineoplastic combined chemotherapy protocols
Docetaxel
androgen receptor antagonists
Hormone-sensitive prostate cancer metastatic
neoplasm metastasis
Hormone sensitive prostate cancer (disorder)
adult
darolutamide
Darolutamide/Docetaxel Regimen
evaluation of the transparency committee
prostatic neoplasms
darolutamide
---